Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
Open Access
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 2 (1) , 1-34
- https://doi.org/10.1186/1476-4598-2-34
Abstract
Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized that comprehensive analysis of four biomarkers modulating angiogenesis in PCa progression in two diverse populations might explain the variance in the incidence rates.Keywords
This publication has 45 references indexed in Scilit:
- Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migrationOncogene, 2003
- Effect of antisense oligonucleotide to annexin II on the t-PA-mediated plasminogen activationin vitroJournal of Huazhong University of Science and Technology [Medical Sciences], 2002
- Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancerProstate Cancer and Prostatic Diseases, 2002
- Decorin suppresses tumor cell-mediated angiogenesisOncogene, 2002
- Molecular Profiling of Angiogenesis MarkersThe American Journal of Pathology, 2002
- The prevalence of high‐grade prostatic intraepithelial neoplasia in surgical resection specimensCancer, 2002
- Identification of Annexin II Heterotetramer as a Plasmin ReductaseJournal of Biological Chemistry, 2002
- INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVOJournal of Urology, 2000
- Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growthCell and tissue research, 1999
- Altered expression of annexin II in human B-cell lymphoma cell linesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996